• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Denmark·Healthcare·MONSO.CO
Share

Monsenso A/S Stocks

DKK 0.24Last Updated 14.08.2026

Issuer Rating

3/7
Performance

Average

Risk

High

Recommendation

Sell

Market Cap

DKK 2.87M

DKK 0.24
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very low or no dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Monsenso A/S, established in Copenhagen, Denmark in 2013, specializes in developing and marketing digital health solutions for the treatment of mental disorders. The company offers a multi-faceted platform, including a dedicated Monsenso app for individuals, which assists users with self-assessments, questionnaires, sensor data collection from personal devices, medication and session reminders, visual progress tracking, motivational feedback, and psychoeducation incorporating cognitive behavioral therapy. A separate application is available for caregivers, providing self-assessment tools, questionnaires, educational content, and various learning resources. For healthcare professionals, Monsenso provides a clinical web portal designed for visualizing patient data, managing patient dashboards, reviewing historical overviews, conducting correlation analysis, facilitating secure messaging, supporting shared decision-making, and maintaining medical records. Additionally, clinicians have access to data analytics features, enabling the aggregation of historical health and behavioral data, statistical descriptions, analysis of correlations between behavior and illness progression, pattern identification, predictive mood forecasting, and risk assessment. The company's innovative tools are utilized by patients, their caregivers, clinical staff, healthcare systems, and researchers.

Company Valuation

Fairly valued
4/7

Based on key historical and expected multiples, the stock is fairly valued relative to its peers.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

15.08.2026 16:01

Small caps last week: Playboy's pivot, AbCellera trial win, GLP-1 boon for AirSculpt

15.08.2026 13:01

A New Leader from China, Billionaires in Soccer, and Ray Dalio's Party

15.08.2026 03:06

Alphabet, Delta, and Construction: Where Buffett's Successor Invested

15.08.2026 02:58

Shares of U.S. drone manufacturers surged following Trump's new tariffs

15.08.2026 02:44

The market is unfazed by the stock decline: Wall Street's fear index is at its lowest level since December

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026